Review




Structured Review

Enzyme Research Laboratories human α-thrombin ht 1002a
Human α Thrombin Ht 1002a, supplied by Enzyme Research Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/human+%CE%B1+thrombin+ht+1002a/pm40499720-58-0-6
Average 90 stars, based on 1 article reviews
human α-thrombin ht 1002a - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Purification:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.

Concentration Assay:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.

Coagulation:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.

Control:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.

Produced:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.

Dissolution:

Article Title: Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
Article Snippet: A PEG‐thrombin solution was created by adding human α‐thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL −1 .

Article Title: Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C.
Article Snippet: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael’s Hospital, Toronto, Ontario, Canada Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China Qingdao Medical College of Qingdao University, Qingdao, Shandong, China Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao, Shandong, China Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada

Article Title: Modeling Hepatocellular Carcinoma and its microenvironment on a chip Hepatocellular carcinoma PDChip
Article Snippet: Thrombin (Enzyme Research Laboratories, HT 1002A) was diluted in complete MV2 to a concentration of 1U/mL.

Article Title: The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects.
Article Snippet: Almost all currently approved anticoagulants interfere with hemostasis and increase the risk of bleeding complications.. Thus, there is a critical need for safer anti-thrombotic drugs without bleeding risk.. Hirudin has demonstrated potent antithrombotic properties, but is clinically limited due to its high bleeding risk.

Article Title: A microvascularized in vitro liver model for disease modeling and drug discovery.
Article Snippet: Cells were mixed at appropriate densities with 5 mg/mL end 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 A cc ep te d M an us cr ip t 143 concentration Fibrinogen (Enzyme Research Laboratories #FIB1) and 0.1 U/mL end concentration thrombin 144 (Enzyme Research Laboratories # HT 1002a).

Article Title: Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis.
Article Snippet: A PEG-thrombin solution was created by adding human α-thrombin (Enzyme Research Laboratories, HT 1002a) to the PEG stock solution to achieve a final thrombin concentration of 0.5 U mL−1.

Article Title: Speckle fluctuations reveal dynamics of microparticles in fibrin scaffolds in a model of bacterial infection
Article Snippet: Purified fibrin scaffolds (Fig. ) were prepared with plasminogen-depleted human fibrinogen (Enzyme Research Laboratories, FIB 1), Alexa Fluor 488-conjugated human fibrinogen (Thermo Fisher Scientific, F13191 ), and human α-thrombin (Enzyme Research Laboratories, HT 1002a) in HBS buffer (20 mM HEPES, 135 mM NaCl, 5 mM CaCl2, pH 7.4) at a final concentration of 5 mg/mL fibrinogen and 2 U/mL thrombin.



Similar Products

94
Thermo Fisher human α thrombin
Human α Thrombin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/alpha+Thrombin+Native+Protein/pm42797476-255-0-5
Average 94 stars, based on 1 article reviews
human α thrombin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Enzyme Research Laboratories human alpha thrombin
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Human Alpha Thrombin, supplied by Enzyme Research Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/human+thrombin+%CE%B1/pmc13116384-152-0-6
Average 86 stars, based on 1 article reviews
human alpha thrombin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Thermo Fisher human α thrombin native protein
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Human α Thrombin Native Protein, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/THROMBIN/bio_rxiv__64898__2026__03__30__714774-149-14-28
Average 96 stars, based on 1 article reviews
human α thrombin native protein - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Sysmex Corporation human α thrombin
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Human α Thrombin, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/human+thrombin+%CE%B1/pmc12859844-92-13-17
Average 86 stars, based on 1 article reviews
human α thrombin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Yeasen Biotechnology human α thrombin
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Human α Thrombin, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/human+thrombin+%CE%B1/pm40812128-53-13-20
Average 86 stars, based on 1 article reviews
human α thrombin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Prolytix human α-thrombin
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Human α Thrombin, supplied by Prolytix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/human+%CE%B1+thrombin/pmc11909436__BLOODA_ADV___2024___013810___mmc1-1-39-44
Average 90 stars, based on 1 article reviews
human α-thrombin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biopharm GmbH enzyme human α-thrombin
( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human <t>alpha</t> <t>thrombin</t> at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.
Enzyme Human α Thrombin, supplied by Biopharm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+alpha-thrombin/bovine+thrombin/us12351648-2087-12-15
Average 90 stars, based on 1 article reviews
enzyme human α-thrombin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human alpha thrombin at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.

Journal: Gels

Article Title: Origin of the High Variability in Sol–Gel Phase Transitions: The Agar Gelation Model

doi: 10.3390/gels12040304

Figure Lengend Snippet: ( a ) Kinetic profiles of the cold-induced reversible gelation of 0.25% agar at 25 °C (absorbance changes at 350 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters of agar are A = 0.132, B = 12.087, C = 1.731, m = 0.00044, and q = −0.009. Derived kinetical parameters for agar gelation are Abs Max = 0.132, V Max = 0.007 Abs/min, t VMax = 5.9 min, and t AbsMax/2 = 11.9 min. Considering the crucial timings t 0 , t lag , t VMax , t AbsMax/2 and t AbsMax , five phases can be identified: I (lag phase), IIa (increase up to maximum rate), IIb (approximately constant-rate increase), IIIa (decelerating increase), and IIIb (plateau with a slight asymptotic drift); see main text for further details; ( b ) Kinetic profiles of the enzymatic assay of 8 μM S–2238 catalyzed by 0.15 nM human alpha thrombin at 25 °C (absorbance changes at 405 nm plotted vs. time) and their corresponding fitted curves (continuous line, ―). According to Equation (3), the fitting parameters for S–2238 are A = 0.139, B = 15.048, C = 1.742, m = −0.000027, and q = 0.005. Derived kinetical parameters for S–2238 enzymatic assay are Abs Max = 0.136, V Max = 0.006 Abs/min, t VMax = 7.2 min, and t AbsMax/2 = 14.9 min. Contrariwise, for the enzymatic reaction only IIa, IIb, IIIa and IIIb phases can be distinguished.

Article Snippet: Human alpha thrombin was purchased by Enzyme Research Laboratories (South Bend, IN, USA).

Techniques: Derivative Assay, Enzymatic Assay